IOP, Inc. Announces Promotion of Erik Melling to Director of Sales U.S.

Print This Post

COSTA MESA, California – March 1, 2000 – IOP, Inc., the premier developer and distributor of specialty devices for surgery, announced today the promotion of Erik Melling to Director of Sales-U.S. This new appointment is effective immediately.

melling IOP, Inc. Announces Promotion of Erik Melling to Director of Sales U.S. Melling, 31, initially teamed up with IOP in 1992 as an independent surgical representative, and immediately established himself as a revenue leader, industry expert and spiritual leader. In October of 1998, Erik joined IOP full-time as the Director of Sales-Eastern Region. Revenues under his leadership expanded almost 50% within the delegated territory.

His new position with the company will allow the company and customers to benefit from Erik’s sales and surgical expertise on a national level. He will be responsible for managing, hiring and promotion of all sales personnel; establishment of territorial revenue goals; and the formulation and implementation of company-wide, revenue-generating incentive plans.

Erik began his career in surgical sales in 1991. He has extensive experience and expertise in anterior segment ophthalmic surgery, microsurgery and surgical instrumentation. He graduated in 1991 from George Mason University with a B.S. in Marketing.

IOP, Inc. is committed to improving the quality of life of people worldwide…to elevating surgical performance through ideas, innovation and technology.


About IOP Ophthalmics Founded in 1988, IOP, Inc. develops and commercializes specialized, leading-edge surgical technologies for eye surgery. IOP's purpose is to develop surgical solutions that improve the quality of life for patients, elevate the performance and productivity of eye care professionals, and lower costs to the provider. IOP currently holds leadership positions with surgical devices for oculoplastic surgeries and bio-implant technologies for cornea, anterior and oculoplastic surgeries.

This entry was posted in News. Bookmark the permalink.

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>